Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CTIM-76 by Context Therapeutics for Testicular Cancer: Likelihood of Approval
CTIM-76 is under clinical development by Context Therapeutics and currently in Phase I for Testicular Cancer. According to GlobalData, Phase...
CTIM-76 by Context Therapeutics for Ovarian Cancer: Likelihood of Approval
CTIM-76 is under clinical development by Context Therapeutics and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase...
CTIM-76 by Context Therapeutics for Endometrial Cancer: Likelihood of Approval
CTIM-76 is under clinical development by Context Therapeutics and currently in Phase I for Endometrial Cancer. According to GlobalData, Phase...